ESC 365 - Doctor Lili Xu

Speaker illustration

Doctor Lili Xu

Zhongshan Hospital Fudan University, Shanghai (China)

Dapagliflozin decreases atherosclerotic plaque instability via regulating macrophage pyroptosis

Event: ESC Congress 2023

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Therapeutic strategies to combat vascular disease

Dapagliflozin decreases atherosclerotic plaque instability via regulating macrophage pyroptosis

Event: ESC Congress 2021 - The Digital Experience

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Congress committee e-posters choice in basic science

11-year follow-up outcomes of catheter ablation of para-hisian accessory pathways

Event: EHRA 2021

Topic: Catheter Ablation of Arrhythmias

Session: ePoster session

Histamine promotes atherosclerotic plaque instability via STAT6-dependent macrophage pyroptosis

Event: ESC Congress 2019

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Atherosclerosis and vascular dysfunction

Stat4 deficiency exacerbates atherosclerosis through promoting foam cell formation via pi3k/akt/nfkb/mir-9/acat1 pathway in ApoE-/- mice

Event: ESC Congress 2018

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Inflammation as a critical component of atherosclerosis

Histamine promotes the differentiation of macrophages from CD11b+ myeloid cells and formation of foam cells through a STAT6-dependent pathway

Event: ESC Congress 2017

Topic: Atherosclerosis

Session: Atherosclerosis

STAT4 deficiency exacerbates atherosclerosis by promoting mobilization of myeloid cells, polarization of M1 macrophages and formation of foam cells

Event: ESC Congress 2016

Topic: Atherosclerosis

Session: Therapeutic modulation of the immune response in atherosclerosis

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources